Doubling of serum creatinine
Also known as: Doubling of creatinine
Drug | Drug Name | Drug Description |
---|---|---|
DB08907 | Canagliflozin | A sodium-glucose co-transporter 2 (SGLT2) inhibitor used to manage hyperglycemia in type 2 diabetes mellitus (DM). Also used to reduce the risk of major cardiovascular events in patients with established cardiovascular disease and type 2 DM. |
Drug | Drug Name | Phase | Status | Count |
---|